Investigation of Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. (SRNE) Accused of Misleading Shareholders On May 15, 2020, Sorrento announced that it had discovered an antibody that had “demonstrated 100% inhibition of SARS-CoV-2 virus infection” and